Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for BAQSIMI

Brand name

BAQSIMI

Company Name

AMPHASTAR PHARMACEUTICALS, INC.

Drug Identification Number

02492415

Ingredients & Strength

GLUCAGON (3 MG)

ATC Code

H04AA

ATC Descriptor

GLYCOGENOLYTIC HORMONES

Status

MARKETED

Shortage reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports
BAQSIMI	3 mg per container	Resolved	2024-02-22	2024-02-28	220276
BAQSIMI	3 mg glucagon per device	Resolved	2024-08-20	2024-09-23	235530
BAQSIMI	3 mg glucagon per device	Resolved	2024-10-10	2024-10-23	239831
BAQSIMI	3 mg glucagon per device	Resolved	2024-11-11	2024-11-20	242464
BAQSIMI	3 mg glucagon per device	Resolved	2025-01-06	2025-03-19	246858
BAQSIMI	3mg glucagon per device	Resolved	2025-04-16	2025-05-02	255162
BAQSIMI	3mg glucagon per device	Resolved	2025-05-05	2025-07-16	256705
BAQSIMI	3mg glucagon per device	Resolved	2025-07-29	2025-08-13	263741

1

Showing 1 to 8 of 8

Discontinuation reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports

1

Showing 1 to 0 of 0